Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5) - Schuler, E; Giagounidis, A; Haase, D (Leukemia, 2016)
. doi:10.1038/leu.2015.340